According to Sino Biopharmaceutical's latest financial reports the company's total assets are โน769.30 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โน749.09 B | -2.54% |
2022-12-31 | โน768.65 B | 8.69% |
2021-12-31 | โน707.19 B | 33.59% |
2020-12-31 | โน529.37 B | 38.24% |
2019-12-31 | โน382.95 B | 29.74% |
2018-12-31 | โน295.17 B | 43.65% |
2017-12-31 | โน205.47 B | 14.21% |
2016-12-31 | โน179.91 B | 27.11% |
2015-12-31 | โน141.53 B | 22.09% |
2014-12-31 | โน115.92 B | 45.78% |
2013-12-31 | โน79.52 B | 46.03% |
2012-12-31 | โน54.45 B | 28.75% |
2011-12-31 | โน42.29 B | 30.29% |
2010-12-31 | โน32.46 B | 44.11% |
2009-12-31 | โน22.52 B | 10.99% |
2008-12-31 | โน20.29 B | 55.95% |
2007-12-31 | โน13.01 B | 3.27% |
2006-12-31 | โน12.60 B | 1.42% |
2005-12-31 | โน12.42 B | 134.2% |
2004-12-31 | โน5.30 B | 22.76% |
2003-12-31 | โน4.32 B | 18.34% |
2002-12-31 | โน3.65 B | 36.29% |
2001-12-31 | โน2.67 B |